A Phase 2 Randomized, Open-Label, Multisite Trial to Inform Public Health Strategies Involving the Use of MVABN Vaccine for Mpox
Clinical Trial Grant
Awarded By
Leidos Biomedical Research, Inc.
Start Date
March 21, 2023
End Date
March 31, 2025
Awarded By
Leidos Biomedical Research, Inc.
Start Date
March 21, 2023
End Date
March 31, 2025